Alveolar echinococcosis of the liver: Percutaneous stent therapy in Budd-Chiari syndrome

J. Vogel*, J. Görich, E. Kramme, E. M. Merkle, R. Sokiranski, P. Kern, H. J. Brambs

*Corresponding author for this work
30 Citations (Scopus)


Background and Aims - Infiltration of the hepatic veins in alveolar echinococcosis can lead to the development of the Budd-Chiari syndrome. The medical and surgical treatment of this condition is generally unsatisfactory. The results of successful interventional treatment with percutaneous stent implantation in the hepatic veins are reported. Methods - Using a transjugular approach, metal mesh stents (Boston Scientific, Medi-Tech Accuflex 8/60 mm) were placed in the median and left hepatic veins of a 53 year old woman. After the intervention, oral chemotherapy with albendazole (2 x 400 mg/day) was continued, but no anticoagulants were given. Results - Stent placement was performed without complications. The clinical picture improved rapidly: normalisation of portal blood flow was confirmed by Doppler ultrasound and there was improvement of liver function, reduction of oesophageal varices, and disappearance of ascites. A follow up examination at 15 months showed no evidence of stent occlusion. Conclusions - Treatment of portal hypertension in alveolar echinococcosis of the liver is problematic. In selected patients with portal hypertension secondary to hepatic vein stenoses but no cirrhosis, percutaneous stent placement in the hepatic veins represents a promising treatment alternative.

Original languageEnglish
Issue number5
Pages (from-to)762-764
Number of pages3
Publication statusPublished - 1996

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)


Dive into the research topics of 'Alveolar echinococcosis of the liver: Percutaneous stent therapy in Budd-Chiari syndrome'. Together they form a unique fingerprint.

Cite this